James A Benzmiller, M.D. is a dermatopathology dermatology in Mankato, MN with 30 years of experience. The provider is a dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes. James A Benzmiller, M.D. NPI is 1992748594. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1994
The provider's business location address is:
1400 E MADISON AVE STE 400A
MANKATO, MN
ZIP 56001-805
Phone: (507) 625-1811
The NPI 1992748594 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Destruction of 2-14 skin growths (HCPCS:17003)
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Destruction of skin growth (HCPCS:17000)
- Special stained specimen slides to examine tissue (HCPCS:88341)
- Tissue or cell analysis by immunologic technique (HCPCS:88342)
- Biopsy of single growth of skin and/or tissue (HCPCS:11100)
- Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
- Biopsy of each additional growth of skin and/or tissue (HCPCS:11101)
- Destruction of up to 14 skin growths (HCPCS:17110)
The enumeration date for this NPI number is 6/13/2006 and was last updated on 7/9/2020.